In clinical practice across Nigeria, dangerous drugs—more commonly referred to as controlled substances or schedules of narcotics—demand strict regulatory oversight. These medications carry a high potential for abuse, physical dependence, and psychological addiction. Midwives and nurses frequently handle agents such as pethidine, pentazocine, and diazepam for pain relief, eclamptic seizure management, and obstetric sedation. Because these agents possess immense therapeutic value alongside substantial risks, they cannot be managed like routine analgesics or antibiotics. Recognizing the pharmacological class of these agents protects both the vulnerable obstetric population and healthcare personnel from legal and professional liability.
The handling of dangerous drugs in Nigeria is governed by federal legislation and monitored by specialized regulatory bodies. The primary agency charged with this mandate is the National Agency for Food and Drug Administration and Control (NAFDAC), working alongside the Nursing and Midwifery Council of Nigeria (NMCN). Midwives must operate strictly within the boundaries of the extant laws, such as the Poisons and Dangerous Drugs Act. Unauthorized possession, improper dispensing, or lax record-keeping constitutes a severe professional offense that can lead to the immediate revocation of a practicing license and criminal prosecution.
Physical security is the first line of defense against drug diversion in a healthcare facility. Dangerous drugs must be kept in a double-locked steel cupboard fixed securely to a permanent wall. The inner compartment houses the actual medications, while the outer door provides an extra layer of security.
Every ward maintaining dangerous drugs must utilize a dedicated Controlled Drug Register—often called the morphine book or register. This document runs continuously, featuring pre-numbered pages where every receipt, administration, and balance is meticulously documented in ink.
| Action | Documentation Requirement |
|---|---|
| Receipt of Stock | Date, quantity received, source, and signature of receiving officer |
| Administration | Patient name, hospital number, dosage given, time, and prescriber |
| Stock Balance | Running calculation verified after every single transaction |
Erasures, liquid paper, or scribbling out mistakes in the register are strictly prohibited. Errors must be neatly ruled through and countersigned.
Administering a controlled substance requires rigorous bedside verification. Before drawing up any dose, the midwife must cross-check the patient's case note, the prescription sheet, and the drug register. Because many obstetric medications come in ampoules where only a fraction of the volume is prescribed, witnessed wasting is mandatory.
When a portion of a drug is discarded, a second qualified nurse or midwife must independently verify the amount being wasted. Both clinicians must sign the drug register immediately, confirming that the remaining balance matches the written calculation. Failing to secure a witness for wasted medication invites suspicion of diversion and violates clinical protocol.
Despite strict protocols, discrepancies in drug counts can occur due to theft, recording errors, or spillage. A drug discrepancy means the physical count of medications inside the cupboard does not match the balance written in the register.
When a discrepancy is discovered, the midwife in charge must escalate the matter immediately to the nursing unit manager and pharmacist. A formal incident report is initiated, and access to the drug cupboard may be temporarily restricted while an internal audit takes place. Cultivating an environment of transparency ensures that systemic failures or individual misconduct are addressed swiftly before patient safety is compromised.